Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Andrology

Free Subscription Articles published in Prostate Retrieve available abstracts of 32 articles: HTML format Text format

Single Articles

January 2012
1. IDE H , Lu Y, Yu J, China T, et al
   Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
   Prostate. 2012 Jan 30. doi: 10.1002/pros.22492.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ZHANG ZY , Schluesener HJ
   HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.
   Prostate. 2012;72:90-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
3. SLABAKOVA E , Pernicova Z, Slavickova E, Starsichova A, et al
   TGF-beta1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug.
   Prostate. 2011;71:1332-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. NIU Y , Ge R, Hu L, Diaz C, et al
   Reduced levels of 5-alpha reductase 2 in adult prostate tissue and implications for BPH therapy.
   Prostate. 2011;71:1317-24.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
5. KIM WT , Choi YD, Park C, Kim YW, et al
   Parathyroid hormone is not involved in prostate growth in patients with benign prostatic hyperplasia.
   Prostate. 2011;71:1210-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HAVERKAMP JM , Charbonneau B, Crist SA, Meyerholz DK, et al
   An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.
   Prostate. 2011;71:1139-50.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
7. THOMAS LN , Morehouse TJ, Too CK
   Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
   Prostate. 2011 Jun 17. doi: 10.1002/pros.21446.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. LIAO CH , Guh JH, Chueh SC, Yu HJ, et al
   Anti-angiogenic effects and mechanism of prazosin.
   Prostate. 2011;71:976-84.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
9. FUKUTA F , Masumori N, Mori M, Tsukamoto T, et al
   Internal prostatic architecture on transrectal ultrasonography predicts future prostatic growth: natural history of prostatic hyperplasia in a 15-year longitudinal community-based study.
   Prostate. 2011;71:597-603.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
10. CHIRIVA-INTERNATI M , Yu Y, Mirandola L, D'Cunha N, et al
    Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.
    Prostate. 2011 Apr 25. doi: 10.1002/pros.21400.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
11. ROBERT G , Smit F, Hessels D, Jannink S, et al
    Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia.
    Prostate. 2011 Mar 28. doi: 10.1002/pros.21387.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MORI F , Tanigawa K, Endo K, Minamiguchi K, et al
    VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
    Prostate. 2011 Mar 10. doi: 10.1002/pros.21374.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. SUGIMOTO M , Oka M, Tsunemori H, Yamashita M, et al
    Effect of a phytotherapeutic agent, Eviprostat(R), on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
    Prostate. 2011;71:438-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
14. KIM WT , Choi YD, Park C, Kim YW, et al
    Parathyroid hormone is not involved in prostate growth in patients with benign prostatic hyperplasia.
    Prostate. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
15. WANG X , Hickey RJ, Malkas LH, Koch MO, et al
    Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. RICK FG , Schally AV, Block NL, Halmos G, et al
    LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KUSLJIC S , Exintaris B
    The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
    Prostate. 2010;70:1555-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SAITO M , Kazuyama E, Shimizu S, Dimitriadis F, et al
    Muscarinic receptors and their mRNAs in type 2 Goto-Kakizaki diabetic rat prostate.
    Prostate. 2010;70:1533-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
19. ROZSA B , Nadji M, Schally AV, Dezso B, et al
    Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GALLARDO-ARRIETA F , Doll A, Rigau M, Mogas T, et al
    A transcriptional signature associated with the onset of benign prostate hyperplasia in a canine model.
    Prostate. 2010;70:1402-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
21. QUINTAR AA , Doll A, Leimgruber C, Palmeri CM, et al
    Acute inflammation promotes early cellular stimulation of the epithelial and stromal compartments of the rat prostate.
    Prostate. 2010;70:1153-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. OLIVER VL , Anderson C, Ventura S, Haynes JM, et al
    Androgens regulate adenylate cyclase activity and intracellular calcium in stromal cells derived from human prostate.
    Prostate. 2010;70:1222-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
23. QUILES MT , Arbos MA, Fraga A, de Torres IM, et al
    Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH).
    Prostate. 2010;70:1044-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
24. ZHAO Z , Zeng G, Zhong W
    Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SUYAMA T , Shiraishi T, Zeng Y, Yu W, et al
    Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. PEEHL DM , Chen Z, Nolley R
    Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GUPTA S , Wang Y, Ramos-Garcia R, Shevrin D, et al
    Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ZHAO Y , Peng J, Zheng L, Yu W, et al
    Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
    Prostate. 2010;70:899-905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
29. MANNOWETZ N , Wurdinger R, Zippel A, Aumuller G, et al
    Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Prostate. 2010;70:1350-1358.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. EVREN S , Dermen A, Lockwood G, Fleshner N, et al
    Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): A tissue microarray study (TMA).
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
31. SIEJKA A , Schally AV, Block NL, Barabutis N, et al
    Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. MCDOWELL KL , Begley LA, Mor-Vaknin N, Markovitz DM, et al
    Leukocytic promotion of prostate cellular proliferation.
    Prostate. 2010;70:377-89.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: